Company Performance - UnitedHealth Group (UNH) closed at $489.98, reflecting a +1.53% increase compared to the previous day, outperforming the S&P 500's daily loss of 0.31% [1] - Over the past month, shares of UnitedHealth Group have depreciated by 5.03%, underperforming the Medical sector's gain of 0.61% and the S&P 500's gain of 2.73% [1] - The company is expected to announce its earnings on July 16, 2024, with a forecasted EPS of $6.70, indicating a 9.12% increase from the same quarter last year, and revenue expected to be $98.92 billion, a 6.48% increase year-over-year [1] Analyst Estimates - For the full year, Zacks Consensus Estimates project earnings of $27.57 per share and revenue of $398.24 billion, representing changes of +9.75% and +7.16% from the prior year, respectively [2] - Recent changes to analyst estimates reflect positive sentiment towards UnitedHealth Group's business operations and profit generation capabilities [2] - The Zacks Rank system indicates a current rank of 3 (Hold) for UnitedHealth Group, with the Zacks Consensus EPS estimate having moved 0.1% lower in the past month [3] Valuation Metrics - UnitedHealth Group is trading at a Forward P/E ratio of 17.5, which is a premium compared to its industry's Forward P/E of 16.22 [3] - The company has a PEG ratio of 1.4, compared to the Medical - HMOs industry's average PEG ratio of 1.22 [3] Industry Overview - The Medical - HMOs industry is part of the Medical sector and holds a Zacks Industry Rank of 63, placing it in the top 25% of over 250 industries [4] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [4]
UnitedHealth Group (UNH) Increases Despite Market Slip: Here's What You Need to Know